Clover Health Investments ($CLOV) Insider Trading & Smart Money Activity
Clover Health Investments, Corp. ($CLOV) has 8 insider trades on file. In the last 12 months on the open market, no insider bought and 5 insiders sold ($1.51M), net -$1.51M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 5
- Net insider $ (12 mo)
- -$1.51M
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 0
CLOV insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 4 · $120.95K | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 1 · $8.76K | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 3 · $1.38M | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All CLOV insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Reynoso Jamie L.CEO, Medicare Advantage | Sell (Open-market sale) 10b5-1 | 2.01K sh | $9.29K | +5.0% | — | |||||
| Insider | Reynoso Jamie L.CEO, Medicare Advantage | Sell (Open-market sale) 10b5-1 | 8.75K sh | $38.67K | +2.1% | — | |||||
| Insider | Toy AndrewChief Executive Officer | Sell (Open-market sale) 10b5-1 | 318.81K sh | $1.34M | +8.3% | — | |||||
| Insider | Reynoso Jamie L.CEO, Medicare Advantage | Sell (Open-market sale) 10b5-1 | 1.92K sh | $8.76K | -0.7% | — | |||||
| Insider | Jamie ReynosoCEO, Medicare Advantage | Sell (Open-market sale) 10b5-1 | 2.36K sh | $11.28K | +8.5% | -3.7% | Read | ||||
| Insider | Oldakowski Joseph FrankVP OF FINANCE AND CONTROLLER | Sell (Open-market sale) 10b5-1 | 12.10K sh | $58.82K | +2.4% | -10.9% | Read | ||||
| Insider | Karen SoaresChief Legal Officer | Sell (Open-market sale) 10b5-1 | 4.68K sh | $21.58K | +6.9% | -2.7% | Read | ||||
| Insider | Jamie ReynosoCEO, Medicare Advantage | Sell (Open-market sale) 10b5-1 | 6.35K sh | $29.27K | +6.9% | -2.7% | Read |
1W / 1M / 6M = how CLOV moved from the trade or filing date.
Insider trading in CLOV: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Reynoso Jamie L. | CEO, Medicare Advantage | 3 | -$56.72K | Oct 7, 2026 | |
| Toy Andrew | Chief Executive Officer | 1 | -$1.34M | Oct 1, 2026 | |
| Jamie Reynoso | CEO, Medicare Advantage | 2 | -$40.55K | Jun 17, 2026 | |
| Oldakowski Joseph Frank | VP OF FINANCE AND CONTROLLER | 1 | -$58.82K | Jun 16, 2026 | |
| Karen Soares | Chief Legal Officer | 1 | -$21.58K | Jun 15, 2026 |
Frequently asked questions
Are CLOV insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 5 insiders made 8 open-market sales worth $1.51M, a net -$1.51M.
What is the latest insider trade in CLOV?
Reynoso Jamie L., CEO, Medicare Advantage filed a sell (open-market sale) of 2.01K sh worth $9.29K on Oct 7, 2026.
Other healthcare plans stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.